Opening the door to synthetic life

Image
John Lauerman Cambridge/ Mass
Last Updated : Jan 20 2013 | 7:34 PM IST

INNOVATION: It may be used to produce new fuels and create biotech drugs

Harvard University scientists are a step closer to creating synthetic forms of life, part of a drive to design man-made organisms that may one day be used to help produce new fuels and create biotechnology drugs.

Researchers led by George Church, whose findings helped spur the US human genome project in the 1980s, have copied the part of a living cell that makes proteins, the building blocks of life. The finding overcomes a major roadblock in making synthetic self-replicating organisms, Church said today in a lecture at Harvard in Cambridge, Massachusetts.

The technology can be used to program cells to make virtually any protein, even some that don’t exist in nature, the scientists said. That may allow production of helpful new drugs, chemicals and organisms, including living bacteria. It also opens the door to ethical concerns about creation of processes that may be uncontrollable by life’s natural defenses.

“It’s the key component to making synthetic life,” Church said yesterday in a telephone call with reporters. “We haven’t made synthetic life and it’s not our primary goal, but this is a huge milestone in that direction.”

The work may be immediately helpful to companies such as Synthetic Genomics Inc, headed by J Craig Venter, trying to make new organisms that perform specific tasks, such as converting buried coal into methane gas that’s easier to extract from the ground.

Venter’s plan is to create man-made microbes that can help break down the coal in the earth, much as bacteria speed decomposing plant material.

In a conference for alumni at Harvard, Church described how his team assembled a reconstituted ribosome, the first artificial version of the structure capable of remaking itself.

Naturally occurring ribosomes are used now when biotechnology companies genetically engineer cells to make the proteins for vaccines and drugs, such as Genentech Inc.’s Herceptin. Normal ribosomes make some drugs slowly, and others can’t be made at all, said Anthony Forster, a Vanderbilt University pharmacologist who has collaborated with Church on synthetic biology projects.

A man-made, or reconstituted, ribosome may be programmable to make all kinds of molecules, Forster said. ©2009 Bloomebrg News Service

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 09 2009 | 12:24 AM IST

Next Story